BRIGHT MINDS BIOSCIENCES INC.
For the period ended Jun 30, 2026. Filed Aug 17, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 30, 2026 · Filed Aug 17, 2026
Use the contents to explore the available documents and sections.
DRUG$23.00+11.1%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · OUTSTANDING SHARE DATA
OUTSTANDING SHARE DATA
The Company's share capital as of date of this MD&A is:
| Balance | |
|---|---|
| Shares issued and outstanding | 9,864,061 |
| Share purchase warrants | 361,765 |
| Restricted share units | 17,000 |
| Stock options | 426,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.